What PSA level indicates cancer?

There is no single PSA threshold that confirms cancer. A PSA above 4 ng/mL is often used as a prompt for further investigation, but many men at this level do not have cancer. Conversely, some men with prostate cancer have PSA levels below 4. The result must be interpreted in context by a specialist.

What is a dangerously high PSA level?

PSA levels above 20 ng/mL are associated with a higher risk of locally advanced or metastatic prostate cancer. However, "dangerous" depends on multiple factors. A rapid rise in PSA over time (PSA velocity) can be as significant as the absolute number. Any elevated PSA should be reviewed by a urologist.

Can a high PSA be caused by something other than cancer?

Yes. BPH, prostatitis, urinary tract infection, recent ejaculation, vigorous exercise and some medications can all raise PSA levels. This is why PSA is a screening marker, not a diagnostic test, and should always be interpreted alongside other clinical findings.

What is PSA velocity and why does it matter?

PSA velocity is the rate at which PSA levels rise over time. A rapid increase of more than 0.75 ng/mL per year can be a more significant indicator of concern than the absolute PSA level alone. Tracking PSA over time is an important part of monitoring prostate health.

How often should PSA be tested?

For men with no symptoms and average risk, annual or biennial PSA testing from age 50 is commonly recommended, or from age 45 for men with a family history of prostate cancer. Men with elevated PSA may need more frequent monitoring. Your urologist will advise on the right interval for your circumstances.

What happens if my PSA is elevated?

An elevated PSA usually prompts further investigations, which may include a repeat PSA test, a multiparametric MRI of the prostate and, if indicated, a targeted biopsy. The aim is to determine whether significant cancer is present. Not all elevated PSA results lead to a diagnosis of cancer.

What Is A Dangerous PSA Level?

Medically reviewed by Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

There is no single dangerous PSA level that applies to every man. A PSA result must be interpreted in the context of your age, ethnicity, family history, rate of change over time and any symptoms. That said, PSA levels above 20 ng/mL are associated with a higher risk of advanced prostate cancer and warrant urgent specialist assessment. No GP referral is required to see a specialist privately.

Key Takeaways

There is no universally dangerous PSA level — interpretation depends on age, family history and rate of change
PSA above 20 ng/mL is associated with a higher risk of advanced prostate cancer and needs urgent review
A rise of more than 0.75 ng/mL in a year is a warning sign even if the overall level appears normal
High PSA does not automatically mean cancer — BPH, prostatitis and infections can also raise it
A private specialist can review your PSA result in full context, often with same-week availability

What are PSA levels?

Prostate-specific antigen (PSA) is a protein produced by the prostate gland. Measuring PSA levels in the blood is one of the key tools used to assess prostate health. While elevated PSA levels are not always indicative of prostate cancer, they can signal the need for further investigation. Understanding what constitutes a dangerous PSA level requires context, as many factors can influence these results.

PSA levels are measured in nanograms per millilitre (ng/mL) of blood. Higher PSA levels are associated with an increased likelihood of prostate issues, including prostate cancer, benign prostatic hyperplasia (BPH), and prostatitis. Age plays a significant role in determining what is considered normal:

Age group	Generally normal PSA range
40 to 49	Below 2.5 ng/mL
50 to 59	Below 3.5 ng/mL
60 to 69	Below 4.5 ng/mL
70 and over	Below 6.5 ng/mL

These thresholds are not definitive. PSA levels can fluctuate due to various factors including physical activity, medical procedures, and infections.

What is considered a dangerous PSA level?

A PSA level becomes a cause for concern when it suggests a high likelihood of prostate cancer or another serious condition. The key factors to understand are:

Rapid PSA increase (PSA velocity)

Even if your PSA falls within the normal range for your age, a rapid increase over a short period is a warning sign. A rise of more than 0.75 ng/mL in a year warrants further investigation. This rate of change, known as PSA velocity, is often more informative than a single reading in isolation.

Very high PSA levels

PSA levels above 10 ng/mL significantly increase the likelihood of prostate cancer. According to BAUS guidance on raised PSA, the probability of a cancer diagnosis at this level exceeds 50%. Levels above 20 ng/mL are associated with a higher risk of cancer that may have spread beyond the prostate.

Free-to-total PSA ratio

A lower ratio of free PSA to total PSA can indicate a higher cancer risk. Ratios below 25% are often considered a warning sign and may prompt further investigation even when the total PSA is only modestly elevated.

Private PSA Review London

Concerned about your PSA result? Get it reviewed by a specialist.

Mr Ghei can put your PSA result in full context — your age, family history, symptoms and rate of change — and give you a clear picture of what it means. Most patients are seen within days of enquiry. No GP referral required. Consultations from £250.

Book a PSA review
or call 020 3325 4699

What else can cause high PSA levels?

High PSA does not automatically mean cancer. Other conditions and factors that can elevate PSA include:

Benign Prostatic Hyperplasia (BPH) — enlargement of the prostate, common as men age
Prostatitis — inflammation of the prostate, often caused by infection
Recent ejaculation — can temporarily increase PSA levels
Digital rectal examination (DRE) — can cause a slight temporary rise
Urinary tract infections (UTIs) — can lead to elevated readings
Prostate surgery or biopsy — can temporarily spike PSA levels

Diagnosing prostate cancer beyond PSA

PSA tests are a valuable screening tool but are not definitive for diagnosing prostate cancer. Additional tests are often required:

Digital rectal examination (DRE) — a physical examination to detect abnormalities
Multiparametric MRI (mpMRI) — detailed prostate imaging before any biopsy decision
Prostate biopsy — the most definitive way to confirm or rule out cancer

What should you do if you have a high PSA level?

If your PSA is elevated, the most important step is to have it reviewed by a consultant urologist. A specialist will interpret your result in the context of your age, ethnicity and family history, assess PSA velocity from previous readings, advise whether a repeat test, MRI, or biopsy is the right next step, and give you a clear, plain-language explanation of your risk level.

Mr Maneesh Ghei sees new patients privately with same-week availability. No GP referral is required. Book a private prostate screening consultation or call 020 3325 4699.

Frequently Asked Questions

What is a dangerous PSA level?

There is no single dangerous PSA level for all men. PSA above 10 ng/mL significantly raises the likelihood of prostate cancer, and levels above 20 ng/mL are associated with a higher risk of advanced disease. Rate of change and age-adjusted thresholds matter just as much as the absolute number. A specialist review gives the full picture.

What PSA level is too high for your age?

Generally, PSA above 2.5 ng/mL in men aged 40-49, above 3.5 in men aged 50-59, above 4.5 in men aged 60-69, and above 6.5 in men aged 70 and over is considered elevated. However, a rising PSA — even within the normal range — is often more concerning than a stable elevated result.

Does a high PSA always mean prostate cancer?

No. BPH, prostatitis, UTIs, recent ejaculation and certain medications can all raise PSA without cancer being present. PSA is a screening indicator, not a diagnostic test. Further investigation is needed to determine the cause.

How quickly can PSA levels rise?

PSA velocity of more than 0.75 ng/mL per year is considered clinically significant. Rapid rises over a shorter period are taken seriously and usually prompt further investigation including an MRI.

Can I get a private PSA test without a GP referral?

Yes. Mr Ghei accepts self-referrals for private PSA testing and prostate consultations. Results are typically available within 2 to 3 working days.

What happens after a high PSA result?

Your specialist will recommend the appropriate next step — which may be a repeat test, an mpMRI scan, or a targeted biopsy. Not every elevated PSA requires a biopsy. A consultant urologist can help you avoid unnecessary procedures while ensuring nothing serious is missed.

About the Author

Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Mr Maneesh Ghei is a consultant urological surgeon with NHS and private practice across four London hospitals. He specialises in the diagnosis and management of prostate conditions including BPH, prostatitis and prostate cancer, as well as urinary symptoms, kidney stones and male sexual health. Mr Ghei sees new patients privately with same-week availability. No GP referral is required. Book a prostate screening consultation.

Need help to book a consultation or got an enquiry regarding what tests you may need?

Fill in your details and we will contact you

Your first name

Last Name

Phone Number

Email Address

What do you need help with?

Private Insurance or Self Pay

Additional information (optional)

🔒 Your data is secure. We’ll only use it to arrange your appointment.

Maneesh Ghei

Mr Maneesh Ghei MS MRCSEd MD (UCL) FRCS (Urol) is a highly experienced Consultant Urological Surgeon and founder of Urocare London, with over three decades of practice in both NHS and private settings across the capital. As Lead Cancer Clinician at Whittington Hospital, Archway, he chairs the multidisciplinary urology cancer meeting, overseeing patient care from diagnosis through to the latest minimally invasive treatments. A pioneer in complex endourology and stone disease management, Mr Ghei led the UK’s first randomised, double-blind trial of intradetrusor botulinum toxin for refractory overactive bladder. He holds an MBBS and MS in General Surgery from India, an MD from University College London, and undertook advanced fellowships in stone disease and laparoscopic surgery, culminating in his Fellowship of the Royal College of Surgeons (Urology). Committed to education and research, he supervises doctoral work in focal therapies and cryotherapy for prostate cancer and champions public awareness through annual Movember fundraising.